Immuron Limited furnishes ASX notices via Form 6-K

Immuron Limited submitted a Form 6-K as a foreign private issuer for December 2025.

Accepted by SEC EDGAR 12/15/2025 - 06:32 AM EST Learn about SEC filing dates

Rhea-AI Filing Summary

Immuron Limited submitted a Form 6-K as a foreign private issuer for December 2025. The company is furnishing to U.S. investors two announcements it released to the Australian Securities Exchange on December 15, 2025, including an application for quotation of securities and a cleansing notice.

The materials are provided as exhibits to the Form 6-K and are expressly stated not to be treated as filed for Exchange Act purposes or automatically incorporated into other U.S. securities filings unless specifically referenced.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Immuron Limited (IMRN) disclose in this December 2025 Form 6-K?

Immuron Limited’s Form 6-K furnishes two announcements previously lodged with the Australian Securities Exchange on December 15, 2025. These include an application for quotation of securities and a cleansing notice, making the same information available to U.S. investors through the SEC system.

What exhibits are attached to Immuron Limited’s (IMRN) December 2025 Form 6-K?

The Form 6-K includes two exhibits: Exhibit 99.1 is an application for quotation of securities, and Exhibit 99.2 is a cleansing notice. These documents replicate announcements previously provided to the Australian Securities Exchange on December 15, 2025.

Are the documents in Immuron Limited’s (IMRN) Form 6-K considered filed under the Exchange Act?

The Form 6-K specifies that the report, including its exhibits, is not deemed filed for purposes of the Securities Exchange Act of 1934. It also notes that the materials are not incorporated into other U.S. filings unless expressly referenced there.

How is Immuron Limited (IMRN) using Form 6-K in relation to its ASX announcements?

Immuron uses Form 6-K to furnish to the SEC the same information it provided to the Australian Securities Exchange on December 15, 2025. This aligns U.S. market disclosure with its ASX announcements on securities quotation and cleansing matters.

Who signed Immuron Limited’s (IMRN) December 2025 Form 6-K submission?

The Form 6-K was signed on behalf of Immuron Limited by Company Secretary Phillip Hains, dated December 15, 2025. His signature confirms that the registrant has duly caused the report to be submitted under the requirements of the Securities Exchange Act of 1934.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 6-K: How Foreign Companies Report to the SEC →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 6-K

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16 UNDER

THE SECURITIES EXCHANGE ACT OF 1934

For the Month of December 2025

Commission File Number: 001-38104

IMMURON LIMITED

(Name of Registrant)

Level 3, 62 Lygon Street, Carlton South, Victoria, 3053, Australia

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F ☒       Form 40-F ☐

Indicate by check mark whether by furnishing the information contained in this Form, the registrant is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.

Yes ☐       No ☒

If “Yes” is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82-

IMMURON LIMITED

EXPLANATORY NOTE

Immuron Limited (the “Company”) published two announcements (the “Public Notices”) to the Australian Securities Exchange on December 15, 2025 titled:

	99.1	Application for quotation of securities
	99.2	Cleansing Notice

A copy of the Public Notice is attached as an exhibit to this report on Form 6-K.

This report on Form 6-K (including the exhibit hereto) shall not be deemed to be “filed” for purposes of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) and shall not be incorporated by reference into any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing.

1

EXHIBITS

Exhibit Number		Description
99.1		Application for quotation of securities
99.2		Cleansing Notice

2

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	IMMURON LIMITED
Date: December 15, 2025	By:	/s/ Phillip Hains
		Phillip Hains
		Company Secretary

3